Singapore-based generic pharmaceutical firm Eywa Pharma Ptv Ltd has secured $30 million from a group of investors including Eight Roads Ventures India, the proprietary investment arm of FIL, Fidelity International Ltd, and the US-based F-Prime Capital 
Partners.
Envestor Ventures Ltd, together with its affiliates (part of the Shriram Group), also participated in this funding round. Other terms of the deal were not disclosed.
Incorporated in 2015, Eywa is engaged in research and development, manufacture, marketing, sale and distribution of generic finished dosage formulations and provides affordable generic pharmaceuticals across the world.
